GlaxoSmithKline PLC Director/PDMR Shareholding (6628Z)
2020年1月14日 - 3:00AM
RNSを含む英国規制内ニュース (英語)
TIDMGSK
RNS Number : 6628Z
GlaxoSmithKline PLC
13 January 2020
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Ms E Walmsley
=== ============================= =================================================
b) Position/status Chief Executive Officer
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Mr R Connor
=== ============================= =================================================
b) Position/status President, Global Vaccines
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Ms D Conrad
=== ============================= =================================================
b) Position/status SVP, Human Resources
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Mr N Hirons
=== ============================= =================================================
b) Position/status SVP, Global Ethics and Compliance
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Ms S Jackson
=== ============================= =================================================
b) Position/status SVP, Global Communications and CEO Office
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ====================================================================================
a) Name Mr D Jackson
=== ============================= =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
=== ============================= =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ====================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ====================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============== =================================
GBP18.00 7 (partnership shares)
=== ============================= ============== =================================
GBP18.00 7 (matching shares)
============== =================================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =====================================================
e) Date of the transaction 2020-01-10
=== ============================= =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Mr D Redfern
=== ============================= =================================================
b) Position/status Chief Strategy Officer
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Mr R Simard
=== ============================= =================================================
b) Position/status President, Pharmaceuticals Supply Chain
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Mr P Thomson
=== ============================= =================================================
b) Position/status President, Global Affairs
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Ms D Waterhouse
=== ============================= =================================================
b) Position/status Chief Executive Officer of ViiV Healthcare
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ================================================================================
a) Name Ms V Whyte
=== ============================= =================================================
b) Position/status Company Secretary
=== ============================= =================================================
c) Initial notification/ Initial notification
amendment
=== ============================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ================================================================================
a) Name GlaxoSmithKline plc
=== ============================= =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================= =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================= ============ ===============================
GBP18.00 7 (partnership shares)
=== ============================= ============ ===============================
GBP18.00 7 (matching shares)
============ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP18.00
=== ============================= =================================================
e) Date of the transaction 2020-01-10
=== ============================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================= =================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDXLFFBFLEBBQ
(END) Dow Jones Newswires
January 13, 2020 13:00 ET (18:00 GMT)
Gsk (LSE:GSK)
過去 株価チャート
から 3 2024 まで 4 2024
Gsk (LSE:GSK)
過去 株価チャート
から 4 2023 まで 4 2024